Atorvastatin Genericon 40 mg filmom obložene tablete
| Name | Atorvastatin Genericon 40 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-662292623 |
| Active Substance | atorvastatinkalcij trihidrat |
| Composition | svaka filmom obložena tableta sadrži 40 mg atorvastatina u obliku atorvastatinkalcijevog trihidrata |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Genericon Pharma Gesellschaft m.b.H., Graz, Austrija Laboratorios Liconsa S.A., Azuqueca de Henares, Guadalajara, Španjolska |
| Marketing Authorisation Holder | Genericon Pharma Gesellschaft m.b.H., Hafnerstraße 211, Graz, Austrija |
| Marketing Authorisation Date | 14.11.2022 |
| MA Period of Validity | 14.11.2027 |
| Classification Number | UP/I-530-09/21-01/13 |
| Registration Number | 381-12-01/70-22-06 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C10AA05 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
